Merck Alliance to Reduce Disparities in Diabetes

Merck Company Foundation, the philanthropic arm of Merck Pharmaceuticals, has announced a new initiative to reduce disparities in diabetes care. According to the Merck website, the initiative will commit $15 million over the next five years for evidence-based diabetes programs that will:

  • Apply program models that address health care disparities related to type 2 diabetes and its associated conditions or complications among minority, low-income and underserved adult populations
  • Enhance patient and health care provider communication, mobilize community partners, and assist health care organizations to decrease disparities in diabetes care
  • Improve the quality of health care for adults who have or are at risk for type 2 diabetes
  • Decrease health care disparities related to diabetes and its associated conditions or complications
  • Increase public awareness of the problem of health care disparities and diabetes

The initiative is seeking applications from “nonprofit organizations, public or private institutions, universities, colleges, health care organizations, community-based or nongovernmental organizations, as well as state and local governments.” Interested organizations should submit a letter of intent, and selected organizations will be invited to submit a full application. See the Merck website for more.

About author:

Lance Gravlee is Co-Chair of HEAT and Associate Professor in the Department of Anthropology at the University of Florida.

Leave a Reply

Sorry, you can not to browse this website.

Because you are using an outdated version of MS Internet Explorer. For a better experience using websites, please upgrade to a modern web browser.

Mozilla Firefox Microsoft Internet Explorer Apple Safari Google Chrome